| Schedule of Shares Before Re Designation |
a. Ordinary shares before re-designation | Date | | Events | | Number of
shares | | | Par value | | | Amount | | | June 27, 2024 | | Share issued upon incorporation | | | 5,000,000,000 | | | | 0.00001 | | | | 50,000 | | | July 24, 2024 | | Share surrender and cancellation by sole shareholder | | | (4,973,495,000 | ) | | | 0.00001 | | | | (49,735 | ) | | July 24, 2024 | | Re-designate shares into Class A Ordinary Shares | | | (26,505,000 | ) | | | 0.00001 | | | | (265 | ) | | July 24, 2024 | | Re-designate shares into Class B Ordinary Shares | | | (1,995,000 | ) | | | 0.00001 | | | | (20 | ) | | | | Ordinary shares before re-designation issued and outstanding after reorganization | | | — | | | | 0.00001 | | | | — | | b. Class A Ordinary Shares | Date | | Events | | Number of
shares | | | Par value | | | Amount | | | July 24, 2024 | | Re-designate shares into Class A Ordinary Shares | | | 26,505,000 | | | | 0.00001 | | | | 265 | | | January 23, 2025 | | Issue of shares pursuant to IPO* | | | 1,500,000 | | | | 0.00001 | | | | 15 | | | February 6, 2025 | | Issue of shares pursuant to IPO* | | | 225,000 | | | | 0.00001 | | | | 2 | | | August 27, 2025 | | Share Retirement # | | | (18,500,000 | ) | | | 0.00001 | | | | (185 | ) | | August 29, 2025 | | Private Placement ## | | | 1,359,314 | | | | 0.00001 | | | | 14 | | | November 3, 2025 | | Issue of shares pursuant to Private Placement ### | | | 727,272 | | | | 0.00001 | | | | 7 | | | December 16, 2025 | | Issuance of shares pursuant to warrant exercise | | | 500,000 | | | | 0.00001 | | | | 5 | | | March 9, 2026 | | Issuance of shares pursuant to warrant exercise | | | 2,969,905 | | | | 0.00001 | | | | 30 | | | March 26, 2026 | | Issuance of shares pursuant to warrant exercise | | | 200,000 | | | | 0.00001 | | | | 2 | | | | | Class A Ordinary Shares issued and outstanding as of March 31, 2026 | | | 15,486,491 | | | | 0.00001 | | | | 155 | | | * | On January 23, 2025, the Company completed its initial public offering on NASDAQ, under the ticker symbol “SKBL”. Under this offering, 1,500,000 ordinary shares were issued at a price of $4.00 per share. In addition, the Company granted a 45-day option to the underwriter to purchase up to an additional 225,000 ordinary shares at the public offering price, less underwriting discounts, to cover over-allotment, if any. On February 6, 2025, the underwriter exercised the over-allotment option in full to purchase an additional 225,000 ordinary shares. On January 23, 2025, the Company closed its initial public offering and the exercise of the over-allotment option, received net proceeds of US$4,807,322 from the offering after deducting underwriting discounts and offering expenses of US$2,092,678 from the gross proceeds of US$6,900,000. | | # | On August 27, 2025, Supreme Development (BVI) Holdings Limited (“SD”), the Company’s previous controlling shareholder and a company beneficially owned by Mr. Ngo Chiu Lam, our Chief Executive Officer, entered into a definitive securities purchase agreement with Quantum Leap Energy LLC (“QLE”) pursuant to which SD transferred and sold to QLE all 1,995,000 issued and outstanding Class B Ordinary Shares of the Company. Each Class B Ordinary Share entitles the holder to 20 votes per share and votes together with the Class A Ordinary Shares on all matters submitted to shareholders. On March 29, 2026, QLE entered into a securities exchange agreement with Dablam LP to assign and transfer its 1,995,000 Class B Ordinary Shares held by QLE to Dablam LP, in exchange for and against Dablam LP’s concurrent assignment and transfer to QLE of 1,995,000 Class A Ordinary Shares held by Dablam LP. The Company also used approximately $7,000,000 of the gross proceeds from the August 2025 Offering to retire 18,500,000 Class A Ordinary Shares owned by SD (the “Share Retirement”). | | ## | On August 29, 2025, the Company closed its private placement (the “Offering (AUG)”) pursuant to a Securities Purchase Agreement dated August 27, 2025, among the Company and certain accredited investors. Pursuant to the Offering (AUG), the Company issued and sold (i) 1,359,314 Class A Ordinary Shares, par value $0.00001 per share, (ii) 22,990,000 prefunded warrants to purchase Class A Ordinary Shares, (iii) Class A Ordinary Share Purchase Warrant A (“Investor Warrants”) to purchase up to 24,349,314 Class A Ordinary Shares, (iv) Class A Ordinary Share Purchase Warrant B (“Investor Warrants”) to purchase up to 24,349,314 Class A Ordinary Shares, and (v) 1,947,945 Placement Agent Warrants to purchase Class A Ordinary Shares issued to the Placement Agents as compensation. | | ### | On November 3, 2025, the Company closed its private placement (the “Offering (OCT)”) pursuant to a Securities Purchase Agreement dated October 28, 2025, among the Company and certain accredited investors. Pursuant to the Offering (OCT), the Company issued and sold (i) 727,272 Class A Ordinary Shares, par value $0.00001 per share, (ii) 16,643,636 prefunded warrants in lieu of Class A Ordinary Shares (the “Pre-funded Warrants”)), and (iii) 17,370,909 Class A Ordinary Share Purchase Warrants to purchase Class A Ordinary Shares (the “Ordinary Warrants, Investor Warrants”), and (iv) 1,389,673 Placement Agent Warrants to purchase Class A Ordinary Shares issued to the Placement Agents as compensation. | c. Class B Ordinary Shares | Date | | Events | | Number of
shares | | | Par value | | | Amount | | | July 24, 2024 | | Re-designate shares into Class B Ordinary Shares | | | 1,995,000 | | | | 0.00001 | | | | 20 | | | | | Class B Ordinary Shares issued and outstanding as of March 31, 2026 | | | 1,995,000 | | | | 0.00001 | | | | 20 | | As of March 31, 2026, the following Preferred Shares were issued and outstanding: | Date | | Authorized | | Issued & Outstanding | | | Par value | | | Amount | | | January 23, 2026 | | Series A Preferred Shares | | | 47,326,026 | | | | 0.00001 | | | | 473 | | | February 13, 2026 | | Series B Preferred Shares | | | 6,442 | | | | 0.00001 | | | | - | |
|
| Schedule of Warrant Activity |
Warrant activity during the year ended March 31, 2026 is indicated below: | | | Pre-Funded Warrants | | | Investor Warrant A | | | Investor Warrant B | | | Investor Warrants
(Oct 2025) | | | Placement Agent Warrants | | | Total | | | As at March 31, 2025 | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | Issued — August 2025 Offering | | | 22,990,000 | | | | 24,349,314 | | | | 24,349,314 | | | | - | | | | 1,947,945 | | | | 73,636,573 | | | Issued — October 2025 Offering | | | 16,643,636 | | | | - | | | | - | | | | 17,370,908 | | | | 1,389,673 | | | | 35,404,217 | | | Exchanged — January 2026 | | | - | | | | (24,349,314 | ) | | | (24,349,314 | ) | | | - | | | | - | | | | (48,698,628 | ) | | Exercise | | | (3,670,000 | ) | | | - | | | | - | | | | - | | | | - | | | | (3,670,000 | ) | | Issued — Series B Financing | | | - | | | | - | | | | - | | | | - | | | | 804,750 | | | | 804,750 | | | Issued — March 2026 Convertible Notes | | | - | | | | - | | | | - | | | | - | | | | 652,500 | | | | 652,500 | | | As at March 31, 2026 | | | 35,963,636 | | | | - | | | | - | | | | 17,370,908 | | | | 4,794,868 | | | | 58,129,412 | | | Exercise Price | | $ | 0.00001 (par) | | | | - | | | | - | | | $ | 1.50 | | | | $0.73–$2.40 | | | | | | | Expiration Date | | | No stated expiration / 5years | | | | - | | | | - | | | | Nov-30 | | | | August 2030–March 2031 | | | | | |
|